Prospects and limitations of physiologically-based pharmacokinetic modelling for cross-species extrapolation
The transition from experimental findings in animal models to clinical applications in human patients is a key challenge in pharmacology and toxicology. To date, this step still inhibits a significant level of uncertainty explaining amongst others the continuously high attrition rates in pharmace...
Guardado en:
Autor principal: | Lars Kuepfer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
South Valley University
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a94188f39ce3415882c79a550fba59d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biosimilars and the extrapolation of indications for inflammatory conditions
por: Tesser JRP, et al.
Publicado: (2017) -
Comparing current and emerging practice models for the extrapolation of survival data: a simulation study and case-study
por: Benjamin Kearns, et al.
Publicado: (2021) -
Dophamine-dependent disorder of conduct of albino rats with sublimate intoxication in the test of extrapolation deliverance
por: N. L. Yakimova, et al.
Publicado: (2013) -
MEML: A Deep Data Augmentation Method by Mean Extrapolation in Middle Layers
por: Dongchen Liu, et al.
Publicado: (2021) -
Genomic variation across cervid species in respect to the estimation of red deer diversity
por: Kasarda Radovan, et al.
Publicado: (2017)